GO:0008753 NADPH dehydrogenase (quinone) activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008753 describes the molecular function of catalyzing the reaction NADPH + H+ + a quinone = NADP+ + a quinol, also known as NADPH dehydrogenase (quinone) activity.
• This activity is central to quinone reduction, redox homeostasis, and cellular defense against oxidative stress.
• Key enzymes include NQO1 (DT-diaphorase), which is a cytosolic NAD(P)H:quinone oxidoreductase, and mitochondrial NAD(P)H-ubiquinone oxidoreductases.
• The activity is regulated by the redox state of the plastoquinone pool in photosynthetic organisms and by various factors in mammalian systems.
• Modulation of this activity by natural compounds such as ascorbigen and emodin has been demonstrated, affecting NQO1 mRNA and enzyme activity.
• Studying GO:0008753 requires a combination of enzymatic assays, gene editing, and expression profiling to link genotype to redox phenotype.
Description
NADPH dehydrogenase (quinone) activity, defined by the Gene Ontology term GO:0008753, is a molecular function that catalyzes the reduction of quinones using NADPH as the electron donor, producing NADP+ and a quinol. This activity is essential for maintaining cellular redox balance and detoxifying reactive quinones, which can otherwise lead to oxidative stress and cellular damage. Researchers study this activity to understand its roles in xenobiotic metabolism, antioxidant defense, and mitochondrial and photosynthetic electron transport. The enzyme NQO1 (also known as DT-diaphorase) is a well-characterized example of a mammalian NAD(P)H:quinone oxidoreductase that exhibits this activity. In plants and cyanobacteria, NAD(P)H-ubiquinone oxidoreductases and NADPH dehydrogenase supercomplexes contribute to respiratory and photosynthetic electron flow, respectively. Given its broad biological significance, GO:0008753 is a focal point for studies on cancer chemoprevention, neuroprotection, and metabolic regulation.
NADPH dehydrogenase (quinone) activity At A Glance
| GO ID | GO:0008753 |
|---|---|
| GO term | NADPH dehydrogenase (quinone) activity |
| Ontology | molecular_function |
| Synonym | NADPH oxidase, NADPH:(quinone-acceptor) oxidoreductase, reduced nicotinamide adenine dinucleotide phosphate (quinone) dehydrogenase |
| Definition | Catalysis of the reaction: NADPH + H+ + a quinone = NADP+ + a quinol. |
| Major function | Reduction of quinones using NADPH as electron donor, contributing to redox homeostasis and detoxification. |
| Representative enzymes | NQO1 (DT-diaphorase), mitochondrial NAD(P)H-ubiquinone oxidoreductases, cyanobacterial NADPH dehydrogenase supercomplex. |
| Substrates | NADPH, quinones (e.g., ubiquinone, plastoquinone). |
| Products | NADP+, quinol. |
What Is GO:0008753?
GO:0008753 is defined as the catalysis of the reaction: NADPH + H+ + a quinone = NADP+ + a quinol. In other words, it is the enzyme activity that transfers electrons from NADPH to a quinone substrate, reducing the quinone to a quinol while oxidizing NADPH to NADP+. This activity is synonymous with NADPH oxidase (when acting on quinones), NADPH:(quinone-acceptor) oxidoreductase, and reduced nicotinamide adenine dinucleotide phosphate (quinone) dehydrogenase.
Why Is NADPH dehydrogenase (quinone) activity Important in Cell Biology?
NADPH dehydrogenase (quinone) activity is critical for protecting cells against oxidative stress and for maintaining redox balance. By reducing quinones to less reactive quinol forms, it prevents the generation of reactive oxygen species and electrophilic quinones that can damage DNA, proteins, and lipids. This activity is also involved in the bioactivation of certain prodrugs and in the metabolism of xenobiotics. In photosynthetic organisms, it regulates electron flow and protects the photosynthetic apparatus under fluctuating light conditions. In mammals, NQO1 is a key enzyme that is induced by the Nrf2 pathway and is implicated in cancer chemoprevention and resistance to chemotherapy. Therefore, understanding GO:0008753 is essential for developing therapeutic strategies targeting redox-related diseases.
• Protects against oxidative stress by detoxifying quinones and preventing ROS generation.
• Involved in the metabolism of xenobiotics and bioactivation of antitumor drugs.
• Regulates mitochondrial electron transport and energy metabolism.
• Modulates photosynthetic electron flow and protects against photoinhibition in plants and cyanobacteria.
• Associated with cancer chemoprevention through NQO1 induction.
• Potential target for neuroprotective and cardioprotective therapies.
• Plays a role in cellular responses to redox imbalance and inflammation.
• Can be modulated by dietary compounds, offering nutraceutical applications.
• Its dysfunction is linked to increased susceptibility to oxidative damage and disease.
• Serves as a biomarker for redox status in various experimental models.
What Happens During NADPH dehydrogenase (quinone) activity?
Substrate Binding and Electron Transfer
In simple terms: The enzyme grabs NADPH and a quinone, then passes electrons from NADPH to the quinone.
The catalytic cycle begins with the binding of NADPH and a quinone substrate to the enzyme's active site. NADPH donates a hydride ion to the enzyme's flavin cofactor (e.g., FAD in NQO1), which then reduces the quinone to a quinol via a two-electron transfer mechanism. This ping-pong or sequential mechanism ensures efficient electron transfer without releasing semiquinone intermediates, thereby avoiding ROS production.
Quinone Reduction and Product Release
In simple terms: The quinone becomes a quinol, which is released, and NADP+ leaves the enzyme.
Following electron transfer, the reduced quinone (quinol) is released from the active site, along with NADP+. The enzyme is then ready for another catalytic cycle. The reduction of quinones to quinol forms is crucial for detoxification and for maintaining the redox state of the cell. In some cases, the quinol product can participate in further reactions, such as antioxidant recycling.
Regulation by Redox State
In simple terms: The activity can be turned up or down depending on the cell's redox balance.
The activity of NADPH dehydrogenase (quinone) is regulated by the redox state of the cell. For example, in cyanobacteria, the redox state of the plastoquinone pool regulates the expression and activity of the NADPH dehydrogenase supercomplex. In mammalian systems, factors such as the NADPH/NADP+ ratio and the presence of oxidized quinones can influence enzyme activity. This ensures that quinone reduction is matched to cellular demand.
Cellular Localization and Isoforms
In simple terms: Different versions of the enzyme work in different parts of the cell, like the cytosol or mitochondria.
NADPH dehydrogenase (quinone) activity is found in multiple cellular compartments. In the cytosol, NQO1 (DT-diaphorase) is a major enzyme exhibiting this activity. In mitochondria, NAD(P)H-ubiquinone oxidoreductases reduce ubiquinone as part of the respiratory chain. In plants, mitochondrial NAD(P)H-ubiquinone oxidoreductases contribute to respiratory electron transport. This compartmentalization allows for specialized roles in redox metabolism.
Key Genes Involved in GO:0008753 NADPH dehydrogenase (quinone) activity
The following genes and proteins are directly associated with NADPH dehydrogenase (quinone) activity, as evidenced by biochemical and genetic studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NQO1 | Cytosolic NAD(P)H:quinone oxidoreductase (DT-diaphorase) that reduces quinones to hydroquinones. | Studied for cancer chemoprevention, drug metabolism, and oxidative stress response. |
| NDH-1 | Cyanobacterial NADPH dehydrogenase supercomplex involved in photosynthetic electron transport. | Model for redox regulation of photosynthesis. |
| NDH-2 | Type II NAD(P)H dehydrogenase in mitochondria and bacteria, reduces ubiquinone. | Target for understanding respiratory chain and oxidative stress. |
| Complex I | Mitochondrial NADH:ubiquinone oxidoreductase, but can also accept NADPH in some contexts. | Linked to mitochondrial diseases and metabolic disorders. |
| NQO2 | Ribosyldihydronicotinamide:quinone oxidoreductase, a paralog of NQO1. | Implicated in drug metabolism and neuroprotection. |
| G6PD | Glucose-6-phosphate dehydrogenase, generates NADPH for quinone reduction. | Indirectly supports NADPH dehydrogenase activity. |
| Nrf2 | Transcription factor that induces NQO1 expression. | Master regulator of antioxidant response. |
| Keap1 | Negative regulator of Nrf2, controls NQO1 induction. | Target for chemoprevention. |
| P450 oxidoreductase | Can reduce quinones but uses NADPH; distinct from GO:0008753. | Studied for comparison with NQO1. |
| Ubiquinone (CoQ) | Endogenous quinone substrate for mitochondrial NAD(P)H dehydrogenases. | Essential for electron transport and antioxidant function. |
| Plastoquinone | Photosynthetic quinone substrate for cyanobacterial NADPH dehydrogenase. | Regulates photosynthetic electron flow. |
| Emodin | Natural compound that competitively inhibits NADPH-quinone reductase. | Used to study enzyme kinetics and cytotoxicity. |
| Ascorbigen | Dietary compound that modulates NQO1 mRNA and activity. | Nutraceutical research. |
| Short-chain quinones | Synthetic quinones with cytoprotective bioactivity. | Drug development for oxidative stress. |
| DT-diaphorase | Alternative name for NQO1. | Historical and clinical studies. |
| NADPH | Essential cofactor for the reaction. | Central to redox metabolism. |
| Quinone | General substrate class. | Varied depending on enzyme. |
How Is NADPH dehydrogenase (quinone) activity Regulated?
The activity of NADPH dehydrogenase (quinone) is regulated at multiple levels. In cyanobacteria, the redox state of the plastoquinone pool controls the expression and activity of the NADPH dehydrogenase supercomplex, allowing adaptation to changing light conditions. In mammalian cells, the transcription factor Nrf2 induces the expression of NQO1 in response to oxidative stress, a process antagonized by Keap1. Additionally, the activity can be modulated by post-translational modifications and by the availability of NADPH, which is generated by enzymes such as glucose-6-phosphate dehydrogenase. Natural compounds like ascorbigen can upregulate NQO1 mRNA and enzyme activity, while emodin acts as a competitive inhibitor. These regulatory mechanisms ensure that quinone reduction is tightly coupled to cellular redox status.
NADPH dehydrogenase (quinone) activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NQO1 | Cancer chemoprevention, drug resistance | NQO1 knockout cancer cell lines; xenograft models |
| NQO1 | Neurodegeneration | Primary neuronal cultures from NQO1 KO mice; oxidative stress induction |
| NDH-2 | Mitochondrial dysfunction | Yeast or mammalian cells with NDH-2 knockdown; respirometry |
| Nrf2 | Inflammation and oxidative stress | Nrf2 KO mice; LPS-induced inflammation models |
| Emodin target | Cytotoxicity in hepatocytes | Primary rat hepatocytes treated with emodin; enzyme kinetics |
Cancer and Chemoprevention
NQO1, a key enzyme with NADPH dehydrogenase (quinone) activity, is often overexpressed in cancer cells and is considered a target for chemoprevention and therapy. Induction of NQO1 by dietary compounds like ascorbigen protects against carcinogenesis by detoxifying quinones and reducing oxidative DNA damage. Conversely, inhibition of NQO1 by emodin can sensitize cells to oxidative stress and induce cytotoxicity, suggesting a therapeutic strategy for certain cancers. The role of NQO1 in bioactivating antitumor prodrugs is also well documented.
Neurodegeneration
Oxidative stress is a hallmark of neurodegenerative diseases such as Alzheimer's and Parkinson's. NADPH dehydrogenase (quinone) activity, particularly through NQO1, helps maintain redox balance in neurons. Short-chain quinones with cytoprotective bioactivity have been shown to protect neuronal cells by mimicking or enhancing this activity. Therefore, pharmacological activation of this pathway is a potential neuroprotective strategy.
Mitochondrial Dysfunction
Mitochondrial NAD(P)H-ubiquinone oxidoreductases contribute to respiratory chain function and quinone reduction. Dysregulation of these enzymes can lead to mitochondrial dysfunction, increased ROS production, and energy deficits, which are implicated in metabolic disorders and aging. Studying these enzymes provides insights into mitochondrial diseases and potential interventions.
From NADPH dehydrogenase (quinone) activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NQO1 protect against oxidative stress? | NQO1 knockout cell lines (e.g., HCT116) + oxidative stress inducers |
| What is the role of NQO1 in drug metabolism? | Point mutations in NQO1 active site (e.g., Y128, F178) to alter quinone reduction |
| How does Nrf2 regulate NQO1 expression? | Knock-in of Nrf2 binding site mutations in NQO1 promoter; luciferase reporter |
| Can short-chain quinones mimic NQO1 activity? | Overexpression of NQO1 in neuronal cells + treatment with quinones |
| What is the impact of NDH-2 on mitochondrial respiration? | Knockout of NDH-2 in model organisms (e.g., yeast, Drosophila) |
| How does plastoquinone pool redox regulate NDH-1? | Cyanobacterial mutants with altered plastoquinone pool; promoter fusions |
How to Study the NADPH dehydrogenase (quinone) activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADPH oxidation assay | Enzyme activity by decrease in absorbance at 340 nm | Kinetic studies, inhibitor screening |
| qRT-PCR | mRNA levels of NQO1 and related genes | Response to inducers like ascorbigen |
| Western blot | Protein expression and modification | Validation of knockout or overexpression |
| CRISPR knockout | Loss-of-function phenotype | Determining gene necessity in redox defense |
| CRISPR knock-in | Tagged protein expression | Localization and interaction studies |
| Redox biosensors | Intracellular redox state (e.g., NADPH/NADP+ ratio) | Live-cell imaging of oxidative stress |
| Metabolomics | Quinone and quinol levels | Pathway flux analysis |
| RNA-seq | Global transcriptional changes | Identifying Nrf2 target genes |
Enzymatic Activity Assays
NADPH dehydrogenase (quinone) activity is typically measured spectrophotometrically by monitoring the oxidation of NADPH at 340 nm in the presence of a quinone substrate such as ubiquinone or menadione. This assay can be performed with cell lysates or purified enzyme and is used to determine kinetic parameters and inhibitor effects. For NQO1, dicoumarol is used as a specific inhibitor to distinguish its activity from other quinone reductases.
Gene Expression Analysis
Quantitative RT-PCR and Western blotting are used to measure mRNA and protein levels of genes like NQO1 in response to treatments. For example, ascorbigen has been shown to modulate NQO1 mRNA and enzyme activity in cultured liver cells and in rats. RNA-seq can provide a global view of redox-related gene expression changes.
CRISPR-Based Genetic Models
CRISPR/Cas9 knockout, point mutation, and knock-in models are powerful tools to study the function of genes exhibiting NADPH dehydrogenase (quinone) activity. Knockout of NQO1 can reveal its role in detoxification and drug response. Point mutations in the active site can dissect catalytic residues. Knock-in of tagged versions allows for localization and interaction studies. Overexpression models can test gain-of-function effects.
Redox Imaging and Metabolomics
Genetically encoded redox sensors (e.g., roGFP) and metabolomics can assess the impact of NADPH dehydrogenase (quinone) activity on cellular redox state and quinone/quinol ratios. These methods provide real-time readouts of oxidative stress and metabolic flux.
How CRISPR Can Be Used to Study GO:0008753 NADPH dehydrogenase (quinone) activity
Knockout
CRISPR knockout of genes encoding NADPH dehydrogenase (quinone) activity, such as NQO1, allows researchers to study loss-of-function phenotypes. For example, NQO1 knockout cells show increased sensitivity to quinone-induced oxidative stress and altered drug metabolism. Knockout models are essential for validating the specific contribution of a gene to total cellular quinone reductase activity.
Point Mutation
Introducing point mutations in catalytic residues (e.g., in the active site of NQO1) can dissect the mechanism of electron transfer and substrate specificity. For instance, mutations in the FAD-binding domain or substrate-binding pocket can abolish or alter enzyme activity, providing insights into structure-function relationships.
Knock-in
Knock-in of epitope tags (e.g., FLAG, GFP) or reporter genes into endogenous loci enables real-time tracking of protein expression, localization, and interactions. This is particularly useful for studying the subcellular distribution of NQO1 and its dynamics under stress conditions.
Overexpression
Overexpression of NQO1 or other quinone reductases via CRISPR activation or lentiviral delivery can test gain-of-function effects, such as enhanced protection against oxidative stress or increased drug resistance. This approach is valuable for identifying therapeutic targets and for screening compounds that modulate enzyme activity.
How EDITGENE Supports NADPH dehydrogenase (quinone) activity Research
Researchers studying NADPH dehydrogenase (quinone) activity-related genes often need to determine whether a candidate gene is causally involved in redox regulation, detoxification, or disease. EDITGENE provides comprehensive CRISPR-based services to create precise genetic models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for NADPH dehydrogenase (quinone) activity research.
Frequently Asked Questions About NADPH dehydrogenase (quinone) activity
What is NADPH dehydrogenase (quinone) activity?
It is a molecular function defined by GO:0008753, catalyzing the reaction NADPH + H+ + a quinone = NADP+ + a quinol.
What genes are involved in NADPH dehydrogenase (quinone) activity?
Key genes include NQO1, NQO2, NDH-2, and components of the cyanobacterial NDH-1 complex.
What is the role of NQO1 in this activity?
NQO1 (DT-diaphorase) is a cytosolic enzyme that reduces quinones to hydroquinones using NADPH, protecting cells from oxidative stress.
How is NADPH dehydrogenase (quinone) activity measured?
It is commonly measured by spectrophotometric assays monitoring NADPH oxidation at 340 nm in the presence of a quinone substrate.
What diseases are associated with this activity?
It is linked to cancer chemoprevention, neurodegeneration, and mitochondrial dysfunction.
Can natural compounds modulate this activity?
Yes, compounds like ascorbigen upregulate NQO1, while emodin competitively inhibits NADPH-quinone reductase.
What is the difference between NQO1 and NQO2?
NQO1 uses NAD(P)H and reduces quinones, while NQO2 uses dihydronicotinamide riboside and has different substrate specificity.
How does the redox state regulate this activity?
In cyanobacteria, the plastoquinone pool redox state regulates NDH-1 expression and activity.
What CRISPR models are available to study this activity?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes like NQO1.
Why is NADPH dehydrogenase (quinone) activity important for photosynthesis?
In cyanobacteria, it helps balance electron flow and protects against photodamage under fluctuating light.
Conclusion
NADPH dehydrogenase (quinone) activity (GO:0008753) is a fundamental molecular function that maintains redox homeostasis by reducing quinones using NADPH. Its roles span detoxification, antioxidant defense, mitochondrial respiration, and photosynthesis. Dysregulation of this activity is implicated in cancer, neurodegeneration, and metabolic disorders, making it a prime target for therapeutic intervention. Advances in CRISPR gene editing and high-throughput screening are accelerating our understanding of the genes and pathways that control this activity, offering new opportunities for drug discovery and precision medicine.
References
- 1. Mikami K et al.. 1997. [DT-diaphorase].. Gan To Kagaku Ryoho 24(11):1606-10 PMID: 9309161
- 2. Shukla V et al.. 2020. Emodin inhibited NADPH-quinone reductase competitively and induced cytotoxicity in rat primary hepatocytes.. Toxicon 188:117-121 PMID: 33122156
- 3. Watanabe N et al.. 2004. Quinones and glutathione metabolism.. Methods Enzymol 378:319-40 PMID: 15038978
- 4. Ma W et al.. 2008. Redox of plastoquinone pool regulates the expression and activity of NADPH dehydrogenase supercomplex in Synechocystis sp. strain PCC 6803.. Curr Microbiol 56(2):189-93 PMID: 18000704
- 5. Feng Z et al.. 2021. Bioactivity Profiles of Cytoprotective Short-Chain Quinones.. Molecules 26(5) PMID: 33806577
- 6. Wagner AE et al.. 2008. The natural compound ascorbigen modulates NADPH-quinone oxidoreductase (NQO1) mRNA and enzyme activity levels in cultured liver cells and in laboratory rats.. Ann Nutr Metab 53(2):122-8 PMID: 18997460
- 7. Takahashi T et al.. 1996. Characterization of NADPH-dependent ubiquinone reductase activity in rat liver cytosol: effect of various factors on ubiquinone-reducing activity and discrimination from other quinone reductases.. J Biochem 119(2):256-63 PMID: 8882715
- 8. Møller IM et al.. 1993. NAD(P)H-ubiquinone oxidoreductases in plant mitochondria.. J Bioenerg Biomembr 25(4):377-84 PMID: 8226719
